The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-5-methyl-11-sec-butyl-pyrimido[4,5-b][1,4]benzodiazepin-6-one ID: ALA4648947
PubChem CID: 156021526
Max Phase: Preclinical
Molecular Formula: C28H35N7O2
Molecular Weight: 501.64
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCC(C)N1c2ccccc2C(=O)N(C)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc21
Standard InChI: InChI=1S/C28H35N7O2/c1-6-19(2)35-23-10-8-7-9-21(23)27(36)33(4)24-18-29-28(31-26(24)35)30-22-12-11-20(17-25(22)37-5)34-15-13-32(3)14-16-34/h7-12,17-19H,6,13-16H2,1-5H3,(H,29,30,31)
Standard InChI Key: WWDLVMCJDNTBPK-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
19.0962 -15.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9229 -15.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3341 -16.1599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3341 -14.7314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1603 -14.7314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4498 -15.5041 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2546 -15.6338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4686 -16.4286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2675 -16.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4828 -17.4463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2827 -17.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8620 -17.0711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6609 -17.2850 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8747 -18.0839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6694 -18.2978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2544 -17.7129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0533 -17.9269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0405 -16.9181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2416 -16.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6479 -16.2760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8527 -16.0619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6387 -15.2630 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2237 -14.6781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7743 -15.0054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4866 -14.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6817 -14.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5060 -13.2966 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.0868 -12.7117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7632 -12.9274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7632 -12.1050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0199 -13.2767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4168 -12.7062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6285 -12.9448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4361 -13.7470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0357 -14.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8278 -14.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6851 -16.1599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
4 2 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
19 13 1 0
12 20 2 0
20 21 1 0
21 9 2 0
21 22 1 0
22 23 1 0
7 24 1 0
24 25 2 0
26 25 1 0
26 5 2 0
27 26 1 0
27 28 1 0
29 27 1 0
29 30 2 0
31 29 1 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
36 35 1 0
36 4 1 0
31 36 2 0
1 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 501.64Molecular Weight (Monoisotopic): 501.2852AlogP: 4.51#Rotatable Bonds: 6Polar Surface Area: 77.07Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 7.84CX LogP: 4.50CX LogD: 3.92Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.53Np Likeness Score: -1.27
References 1. Ferguson FM, Liu Y, Harshbarger W, Huang L, Wang J, Deng X, Capuzzi SJ, Muratov EN, Tropsha A, Muthuswamy S, Westover KD, Gray NS.. (2020) Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H -benzo[e ]pyrimido[5,4-b ][1,4]diazepin-6-one Scaffold., 63 (14): [PMID:32530623 ] [10.1021/acs.jmedchem.0c00596 ]